These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12670664)

  • 1. Somatostatin infusion withdrawal: a study of patients with migraine, cluster headache and healthy volunteers.
    Levy MJ; Matharu MS; Bhola R; Lightman S; Goadsby PJ
    Pain; 2003 Apr; 102(3):235-241. PubMed ID: 12670664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine and cluster headache show impaired neurosteroids patterns.
    Koverech A; Cicione C; Lionetto L; Maestri M; Passariello F; Sabbatini E; Capi M; De Marco CM; Guglielmetti M; Negro A; Di Menna L; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2019 May; 20(1):61. PubMed ID: 31132992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks.
    Wei DY; Goadsby PJ
    Cephalalgia; 2021 Jul; 41(8):913-933. PubMed ID: 33615843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches.
    Sances G; Tassorelli C; Pucci E; Ghiotto N; Sandrini G; Nappi G
    Cephalalgia; 2004 Feb; 24(2):110-9. PubMed ID: 14728706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet levels of dopamine are increased in migraine and cluster headache.
    D'Andrea G; Granella F; Perini F; Farruggio A; Leone M; Bussone G
    Headache; 2006 Apr; 46(4):585-91. PubMed ID: 16643552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients.
    Waldenlind E; Ross SB; Sääf J; Ekbom K; Wetterberg L
    Cephalalgia; 1985 Mar; 5(1):45-54. PubMed ID: 3921257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache.
    Galeotti N; Ghelardini C; Zoppi M; Del Bene E; Raimondi L; Beneforti E; Bartolini A
    Cephalalgia; 2001 Feb; 21(1):38-45. PubMed ID: 11298662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrin levels in patients with migraine and cluster headache.
    Klimek A
    Eur Neurol; 1982; 21(5):305-8. PubMed ID: 7117318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
    Nicolodi M; Del Bianco E
    Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine and cluster headache - the common link.
    Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
    J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone levels in cluster and non-cluster migrainous headache patients.
    Nelson RF
    Headache; 1978 Nov; 18(5):265-7. PubMed ID: 721458
    [No Abstract]   [Full Text] [Related]  

  • 14. PACAP38 induces migraine-like attacks in patients with migraine without aura.
    Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
    Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergotamine abuse. Do patients benefit from withdrawal?
    Tfelt-Hansen P; Krabbe A
    Cephalalgia; 1981 Mar; 1(1):29-32. PubMed ID: 15645831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication overuse headache.
    Ward TN
    Prim Care; 2004 Jun; 31(2):369-80, vii. PubMed ID: 15172512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood leukotrienes in headache: correlation with platelet activity.
    LaMancusa R; Pulcinelli FM; Ferroni P; Lenti L; Manzari G; Pauri F; Rizzo PA; Gazzaniga PP; Pontieri GM
    Headache; 1991 Jun; 31(6):409-14. PubMed ID: 1889985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma testosterone levels in cluster headache.
    Romiti A; Martelletti P; Gallo MF; Giacovazzo M
    Cephalalgia; 1983 Mar; 3(1):41-4. PubMed ID: 6850820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster Headache Clinical Phenotypes: Tobacco Nonexposed (Never Smoker and No Parental Secondary Smoke Exposure as a Child) versus Tobacco-Exposed: Results from the United States Cluster Headache Survey.
    Rozen TD
    Headache; 2018 May; 58(5):688-699. PubMed ID: 29536529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone test in primary headache sufferers.
    Facchinetti F; Martignoni E; Gallai V; Micieli G; Mercantini F; Nappi G; Genazzani AR
    Cephalalgia; 1987; 7 Suppl 6():39-42. PubMed ID: 3442804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.